Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Zentek Ltd.NASDAQ: ZTEK

EBITDA · Q4 FY2025 · quarter ended Mar 2026

EBITDA remains negative

Q4 FY2025 EBITDA was -CA$3.73M, compared with -CA$1.88M a year earlier. Trailing-twelve-month EBITDA was -CA$9.7M.

Context

  • EBITDA amounted to 6204.7% of revenue in FY2025, up 5133.2 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of -CA$3.86M (+62.7%) for the fiscal year ending Mar 2027, a step up from the -10.5% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$3.73M-41.2% QoQ
Last fiscal yearMar 2026
-CA$10.33M-10.5% YoY
LTMMar 2026
-CA$9.7M-3.8% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-98.1%-218.4%-120.3 pp
1 year-10.5%+62.7%+73.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

CAD · from the income statement

Latest · FY2025
(10.33M) CAD
Year-over-year change
-10.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -3.8% is the 5th highest of 9, against a peer median of +3.4%.
  • EBITDA amounts to 5840.5% of revenue for ZTEK, versus a peer median of 137.8%.
ZTEK Competitors
EBITDA for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BYSIBeyondSpring Inc.LTM Mar 2026-$8.02M USD-9.0%——
ZTEKZentek Ltd.LTM Mar 2026-CA$9.7M CAD-3.8%—5840.5%
HYFTMindWalk Holdings Corp.LTM Jan 2026-CA$10.88M CAD+76.6%—59.3%
MBOTMicrobot Medical Inc.LTM Mar 2026-$14.17M USD-22.2%—13493.3%
HYPRHyperfine, Inc.LTM Mar 2026-$33.15M USD+15.7%—216.2%
CRDLCardiol Therapeutics Inc.LTM Mar 2026-CA$36.27M CAD-16.2%——
AMWLAmerican Well CorporationLTM Mar 2026-$53.01M USD+56.9%—22.3%
ALXOALX Oncology Holdings Inc.LTM Mar 2026-$86.7M USD+32.0%——
GUTSFractyl Health, Inc. Common StockLTM Mar 2026-$106.88M USD-21.2%——
Peer median (excluding ZTEK) —+3.4%—137.8%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue339.67K72.86K29.82K872.5K166.48K
Cost of Revenue376.79K853.34K331.08K680.01K6.47M
Gross Profit(37.12K)(780.48K)(301.26K)192.49K(6.3M)
Gross Margin-10.9%-1071.3%-1010.4%22.1%-3785.5%
Research & Development1.54M1.65M1.78M465.65K1.66M
Selling, General & Admin9.56M10.99M8.95M8.01M2.87M
Operating Expenses12.53M13.87M11.68M9.79M4.56M
Depreciation & Amortization614.71K539.69K613.71K600.32K527.77K
EBITDA(31.02M)(13.75M)(11.08M)(9.35M)(10.33M)
EBITDA Margin-9131.2%-18878.5%-37170.3%-1071.4%-6204.7%
Operating Income(12.56M)(14.65M)(11.98M)(9.6M)(10.86M)
Operating Margin-3698.5%-20112.5%-40174.8%-1100.4%-6521.7%
Interest Income20.6K510.26K405.48K101.61K40.41K
Interest Expense63.78K120.62K107.37K91.32K289.98K
Other Income / Expenses(19.13M)238.68K174.74K(439.03K)1.06M
Income Before Tax(31.69M)(14.41M)(11.8M)(10.04M)(9.79M)
Pre-Tax Margin-9330.9%-19784.9%-39588.7%-1150.7%-5882.6%
Income Tax Expense00(99.78K)00
Net Income(31.69M)(14.41M)(11.7M)(10.04M)(9.79M)
Net Margin-9330.9%-19784.9%-39254.1%-1150.7%-5882.6%
EPS (Basic)(0.42)(0.14)(0.12)(0.10)(0.09)
EPS (Diluted)(0.42)(0.14)(0.12)(0.10)(0.09)
Weighted Avg Shares92.09M99.44M97.53M102.98M105.92M
Weighted Avg Shares (Diluted)92.09M99.44M100.5M102.98M105.92M

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.